Diabetic nephropathy: introduction.
Semin Nephrol. 2007 Mar;27(2):129
AGE, RAGE, and ROS in diabetic nephropathy.
Semin Nephrol. 2007 Mar;27(2):130-43
The renin-angiotensin system and diabetic nephropathy.
Semin Nephrol. 2007 Mar;27(2):144-52
Regulation of transforming growth factor beta in diabetic nephropathy: implications for treatment.
Semin Nephrol. 2007 Mar;27(2):153-60
Angiogenesis in diabetic nephropathy.
Semin Nephrol. 2007 Mar;27(2):161-71
Albuminuria: a target for treatment of type 2 diabetic nephropathy.
Semin Nephrol. 2007 Mar;27(2):172-81
Treating hypertension in the patient with overt diabetic nephropathy.
Semin Nephrol. 2007 Mar;27(2):182-94
Histopathology of diabetic nephropathy.
Semin Nephrol. 2007 Mar;27(2):195-207
Mining the genome for susceptibility to diabetic nephropathy: the role of large-scale studies and consortia.
Semin Nephrol. 2007 Mar;27(2):208-22
The application of the HapMap to diabetic nephropathy and other causes of chronic renal failure.
Semin Nephrol. 2007 Mar;27(2):223-36
Genetics of diabetic nephropathy: lessons from mice.
Semin Nephrol. 2007 Mar;27(2):237-47